400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / Pim / SGI-1776 游离碱
CAS No.: 1025065-69-3
Synonyms: Pim-Kinase Inhibitor IX;SGI-1776 Free Base
SGI-1776 free base is an ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin.
生物活性
靶点 | FLT3 IC50:44nM | Pim1 IC50:7nM | Pim2 IC50:363nM | Pim3 IC50:69nM |
动物研究 | |
剂量 | Mice: 50 mg/kg - 200 mg/kg[2] (p.o.) |
给药途径 | p.o. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01239108 | Relapsed/Refractory Leukemias | Phase 1 | Withdrawn(The dose limiting to... more >>xicity of cardiac QTc prolongation was identified and demonstrated unsafe to continue clinical development of this molecule.) Collapse << | April 2012 | United States, Texas ... more >> MD Anderson Cancer Center Houston, Texas, United States Collapse << |
NCT00848601 | Prostate Cancer ... more >> Non-Hodgkins Lymphoma Collapse << | Phase 1 | Terminated(The dose limiting t... more >>oxicity of cardiac QTc prolongation was identifiedin the phase 1 study in patients with refractory prostate and lymphoma) Collapse << | - | United States, California ... more >> UCLA Los Angeles, California, United States, 90095-1678 United States, Texas Cancer Therapy Research Center San Antonio, Texas, United States, 78229 United Kingdom Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Collapse << |
实验方案
技术信息
CAS号 | 1025065-69-3 | 储存条件 |
|
|||||||||||||
分子式 | C20H22F3N5O | 运输 | 蓝冰 | |||||||||||||
分子量 | 405.42 | 别名 | Pim-Kinase Inhibitor IX;SGI-1776 Free Base | |||||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
CHO cells | - | Function assay | - | Inhibition of human ERG expressed in CHO cells by automated patch clamp method, IC50=1 μM | 25589932 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01239108 | Relapsed/Refractory Leukemias | Phase 1 | Withdrawn(The dose limiting to... more >>xicity of cardiac QTc prolongation was identified and demonstrated unsafe to continue clinical development of this molecule.) Collapse << | April 2012 | United States, Texas ... more >> MD Anderson Cancer Center Houston, Texas, United States Collapse << |
NCT00848601 | Prostate Cancer ... more >> Non-Hodgkins Lymphoma Collapse << | Phase 1 | Terminated(The dose limiting t... more >>oxicity of cardiac QTc prolongation was identifiedin the phase 1 study in patients with refractory prostate and lymphoma) Collapse << | - | United States, California ... more >> UCLA Los Angeles, California, United States, 90095-1678 United States, Texas Cancer Therapy Research Center San Antonio, Texas, United States, 78229 United Kingdom Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Collapse << |
靶点 | Description | IC50 |
---|---|---|
FLT3 | IC50:44nM | |
Pim1 | IC50:7nM | |
Pim2 | IC50:363nM | |
Pim3 | IC50:69nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网